Total Payments
$903.55
2024 Payments
$143.53
Companies
14
Transactions
33
Medicare Patients
1,973
Medicare Billing
$227,663
Payment Breakdown by Category
Food & Beverage$903.55 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $903.55 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $323.61 | 10 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $148.54 | 4 | $0 (2023) |
| Becton, Dickinson and Company | $124.23 | 1 | $0 (2024) |
| QOL Medical, LLC | $62.61 | 3 | $0 (2022) |
| Intercept Pharmaceuticals, Inc. | $39.80 | 3 | $0 (2021) |
| Merck Sharp & Dohme LLC | $36.86 | 2 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $36.30 | 2 | $0 (2021) |
| PFIZER INC. | $32.12 | 2 | $0 (2021) |
| Olympus America Inc. | $24.43 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $19.30 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $143.53 | 2 | Becton, Dickinson and Company ($124.23) |
| 2023 | $52.28 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($38.95) |
| 2022 | $143.98 | 7 | ABBVIE INC. ($51.03) |
| 2021 | $274.28 | 12 | AbbVie Inc. ($169.57) |
| 2020 | $14.02 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($14.02) |
| 2019 | $214.56 | 5 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($109.59) |
| 2018 | $12.86 | 1 | BOSTON SCIENTIFIC CORPORATION ($12.86) |
| 2017 | $48.04 | 2 | Olympus America Inc. ($24.43) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Becton, Dickinson and Company | Bard 3DMax Mesh (Device) | Food and Beverage | In-kind items and services | $124.23 | General |
| Category: Surgery | ||||||
| 05/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Gastroenterology | ||||||
| 05/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Gastroenterology | ||||||
| 03/27/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/08/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Diabetes | ||||||
| 06/13/2022 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 05/09/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: IMMUNOLOGY | ||||||
| 04/07/2022 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: THERAPY FOR CSID | ||||||
| 02/02/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.54 | General |
| 09/30/2021 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 09/27/2021 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/02/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: VIROLOGY | ||||||
| 08/11/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $88.99 | General |
| Category: VIROLOGY | ||||||
| 08/11/2021 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.61 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/06/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: VIROLOGY | ||||||
| 07/01/2021 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 06/22/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/04/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/11/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/06/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/28/2021 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 12/08/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 559 | 590 | $553,835 | $58,418 |
| 2022 | 7 | 206 | 208 | $225,956 | $21,047 |
| 2021 | 19 | 1,045 | 1,435 | $842,848 | $134,437 |
| 2020 | 7 | 163 | 190 | $52,576 | $13,761 |
Total Patients
1,973
Total Services
2,423
Medicare Billing
$227,663
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 76 | 77 | $130,515 | $14,755 | 11.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 126 | 127 | $210,820 | $9,969 | 4.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 98 | 101 | $33,748 | $9,835 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $16,009 | $5,602 | 35.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 69 | 70 | $102,550 | $5,474 | 5.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 48 | $6,897 | $3,513 | 50.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 25 | $6,012 | $2,512 | 41.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 23 | $6,178 | $2,084 | 33.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 26 | 26 | $31,668 | $2,042 | 6.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,792 | $1,447 | 38.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 19 | $3,560 | $1,144 | 32.1% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 14 | 14 | $2,086 | $40.42 | 1.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 33 | 34 | $57,630 | $6,481 | 11.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 46 | 47 | $15,228 | $4,768 | 31.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 46 | 46 | $76,360 | $3,040 | 4.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 32 | 32 | $46,880 | $2,467 | 5.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $6,838 | $2,202 | 32.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $20,320 | $1,284 | 6.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 15 | $2,700 | $805.20 | 29.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 229 | 245 | $147,735 | $38,646 | 26.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 167 | 426 | $92,381 | $24,074 | 26.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 122 | $22,625 | $12,392 | 54.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 62 | 62 | $96,350 | $11,904 | 12.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 124 | 128 | $126,480 | $9,908 | 7.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 99 | 99 | $125,588 | $8,063 | 6.4% |
About Dr. Kavan Patel, M.D
Dr. Kavan Patel, M.D is a Gastroenterology healthcare provider based in Toms River, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1437541406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kavan Patel, M.D has received a total of $903.55 in payments from pharmaceutical and medical device companies, with $143.53 received in 2024. These payments were reported across 33 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($903.55).
As a Medicare-enrolled provider, Patel has provided services to 1,973 Medicare beneficiaries, totaling 2,423 services with total Medicare billing of $227,663. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Toms River, NJ
- Active Since 02/26/2015
- Last Updated 04/21/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437541406
Products in Payments
- TRULANCE (Drug) $134.80
- Bard 3DMax Mesh (Device) $124.23
- MAVYRET (Drug) $121.65
- SUCRAID (Drug) $62.61
- LINZESS (Drug) $61.39
- SKYRIZI (Biological) $51.03
- OCALIVA (Drug) $39.80
- DIFICID (Drug) $36.86
- ENTYVIO (Biological) $36.30
- XELJANZ (Drug) $32.12
- Olympus EMR & ESD Devices (Device) $24.43
- Humira (Biological) $23.61
- STELARA (Biological) $19.30
- JARDIANCE (Drug) $14.88
- XIFAXAN (Drug) $13.74
- SPYGLASS (Device) $12.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Toms River
Mr. Neil Nagaria, Md, MD
Gastroenterology — Payments: $18,349
Gastroenterology $18,349
Teresa Tacopina, Md, MD
Gastroenterology — Payments: $7,735
Gastroenterology $7,735
Dr. Eric Eschinger, Md, MD
Gastroenterology — Payments: $6,236
Gastroenterology $6,236
Kenneth Glazier
Gastroenterology — Payments: $5,912
Gastroenterology $5,912
Carl Raso, Md, MD
Gastroenterology — Payments: $5,227
Gastroenterology $5,227
Gabrielle Corpuz, Pa-C, PA-C
Gastroenterology — Payments: $4,258
Gastroenterology $4,258